Skip to main content
MediWound Ltd. logo

MediWound Ltd. — Investor Relations & Filings

Ticker · MDWD ISIN · IL0011316309 LEI · 549300LJKCS74GRYKF90 US Manufacturing
Filings indexed 369 across all filing types
Latest filing 2026-04-02 Foreign Filer Report
Country IL Israel
Listing US MDWD

About MediWound Ltd.

https://www.mediwound.com/

MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.

Recent filings

Filing Released Lang Actions
6-K - MediWound Ltd. (0001593984) (Filer)
Foreign Filer Report
2026-04-02 English
3 - MediWound Ltd. (0001593984) (Issuer)
Director's Dealing
2026-03-25 English
3 - MediWound Ltd. (0001593984) (Issuer)
Director's Dealing
2026-03-18 English
3 - MediWound Ltd. (0001593984) (Issuer)
Director's Dealing
2026-03-18 English
3 - MediWound Ltd. (0001593984) (Issuer)
Director's Dealing
2026-03-18 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.